Skip to main content

Table 1 Participant Characteristics n = 327

From: Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer

Parameter

Breakdown

n

%

Sex

Male

129

39.4

Female

198

60.6

Age

60

141

43.1

61

186

56.9

Employment status

Unemployed

87

26.6

Full time employee

84

25.7

Homemaker

76

23.2

Part time employee

40

12.2

Retired

40

12.2

Performance status

0

78

23.9

1

218

66.7

2

31

9.5

Tumor location

Gastrointestinal organs

121

37.0

Breast

79

24.2

Female reproductive organs

47

14.4

Blood/hematopoietic system

40

12.2

Respiratory organs

15

4.6

Other/unknown

25

7.6

Stage

I

25

7.6

II

54

16.5

III

86

26.3

IV

160

48.9

Unknown

2

0.6

CTCAE Peripheral sensory neuropathy

Grade 1

120

36.7

Grade 2

189

57.8

Grade 3

18

5.5

Paresthesia of the hands and feet

hands

45

13.8

feet

33

10.1

Both hands and feet

249

76.1

Drug used

Paclitaxel

146

44.6

Oxaliplatin

85

26.0

Vincristine

33

10.1

Docetaxel

29

8.9

Cisplatin

11

3.4

Carboplatin

2

0.6

Vinblastine

2

0.6

Other

19

5.8

  1. CTCAE Common Terminology Criteria for Adverse Events